New York, New York–(Newsfile Corp. – May 9, 2022) – The law firm Klein announces that a class action lawsuit has been filed on behalf of shareholders of Aurinia Pharmaceuticals Inc. AUPH alleging that the Company violated federal securities laws.
Class period: May 7, 2021 for February 25, 2022
Lead Applicant Deadline: June 14, 2022
No obligation or cost to you.
Learn more about your recoverable losses in AUPH:
Aurinia Pharmaceuticals Inc. NEWS – AUPH NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Aurinia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing a decline in revenue; (ii) Aurinia’s 2022 sales outlook for the Company’s only product it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would be well below expectations; (iii) as a result, the Company had grossly overestimated LUPKYNIS’ business prospects; (iv) as a result, the Company had exaggerated its financial situation and/or its outlook for 2022; and (v) as a result, the Company’s public statements were materially false and misleading at all material times.
WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you have suffered a loss at Aurinia Pharmaceuticals Inc., you have until June 14, 2022 ask the court to obtain the status of principal plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.
AT NO CHARGE TO YOU: If you purchased securities of Aurinia Pharmaceuticals Inc. during the relevant period, you may be entitled to compensation without payment of any disbursement.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Klein Law Firm is a litigation firm with experience in a wide range of areas, including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertisement. Prior results do not guarantee similar results.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123336